IDERA PHARMACEUTICALS Stock Quote

$1.615 arrow  Change: -0.10 %Chge: -5.83% Vol: 86,630
End Of Day Prices
High: 1.71 | Low: 1.615 | Open: 1.695 | Close: 1.615
52 Wk High: 2.86 | 52 Wk Low: 1.36 | Todays Pivot: 1.65
Sector: add stock to watch list

IDRA Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Idera Pharmaceuticals

Idera Pharmaceuticals Inc (NASDAQ:IDRA): Institutional Investor Sentiment Up to 3.89

Idera Pharmaceuticals Inc (NASDAQ:IDRA) institutional sentiment increased to 3.89 in Q4 2017. Its up 2.53, from 1.36 in 2017Q3. The ratio increased, as 70 funds increased or opened new holdings, while 18 sold and trimmed stock positions in Idera ...


Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) enters into a clinical development support agreement with Pillar Partners Foundation

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a Healthcare sector firm, traded 166.50 Million shares in last trading session and stock slipped -5.35% with closing price of $1.77 per share . Company gross margins represents its total sales revenue minus its ...


Shall we date? Description

Hunter and Ver. Witch) for this game. See what adventure your boyfriend can take you! You are a vampire hunter who is about to head to Idra Forest with your partner wolf. The forest is believed to be where the vampire castle is. Your mission is to visit ...


Active-Investors: Blog Exposure - Idera Pharma Announces Clinical Development Support Agreement with Pillar Partners Foundation

LONDON, UK / ACCESSWIRE / April 18, 2018 / Active-Investors.com has just released a free research report on Idera Pharma, Inc. (NASDAQ: IDRA) ("Idera"). If you want access to this report all you need to do is sign up now by clicking the following link www ...


Idera Pharmaceuticals Inc : Blog Exposure - Idera Pharma Announces Clinical Development Support Agreement with Pillar Partners Foundation

The Company is also developing IDRA-008 apolipoprotein C-III gene target for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy; nucleic acid chemistry compound for renal target; and IMO-9200 for treating non-malignant ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Idera Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for IDRA to choose from. Visit here to build your stock quote widget »